Catherine Crombie

409 total citations
6 papers, 148 citations indexed

About

Catherine Crombie is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Catherine Crombie has authored 6 papers receiving a total of 148 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 2 papers in Pathology and Forensic Medicine and 2 papers in Oncology. Recurrent topics in Catherine Crombie's work include Neuroendocrine Tumor Research Advances (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Lung Cancer Research Studies (2 papers). Catherine Crombie is often cited by papers focused on Neuroendocrine Tumor Research Advances (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Lung Cancer Research Studies (2 papers). Catherine Crombie collaborates with scholars based in Australia, United States and New Zealand. Catherine Crombie's co-authors include John Taper, David Gottlieb, Mark Hertzberg, Howard Lau, Andrew J. Brooks, Catherine Shannon, Howard Gurney, Ken Bradstock, Kenneth F. Bradstock and Rhonda Devine and has published in prestigious journals such as Annals of Oncology, European Journal of Cancer and British Journal of Urology.

In The Last Decade

Catherine Crombie

6 papers receiving 147 citations

Peers

Catherine Crombie

ONCOL

PFM

SURGE

PRM

NEURO

Christy Kesslering United States

Juana María Cano Spain

Ole G. Jørgensen Norway

Michelle F. Jacobs United States

Silvia Fanello Italy

J. G. Adami Argentina

Jill Davison Australia

Bradford Siegele United States

Annick Chevalier-Place France

Rowan G. Doig Australia

Christy Kesslering United States

Catherine Crombie

59 ×1.1

ONCOL

26 ×0.5

PFM

33 ×0.7

SURGE

40 ×0.9

PRM

7 ×0.3

NEURO

Citations per year, relative to Catherine Crombie Catherine Crombie (= 1×) peers Christy Kesslering

Countries citing papers authored by Catherine Crombie

Since Specialization

Citations

This map shows the geographic impact of Catherine Crombie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Crombie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Crombie more than expected).

Fields of papers citing papers by Catherine Crombie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Crombie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Crombie. The network helps show where Catherine Crombie may publish in the future.

Co-authorship network of co-authors of Catherine Crombie

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Crombie. A scholar is included among the top collaborators of Catherine Crombie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Crombie. Catherine Crombie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Blinman, Prunella, Brett Hughes, Catherine Crombie, et al.. (2015). Patients’ and doctors’ preferences for adjuvant chemotherapy in resected non-small-cell lung cancer: What makes it worthwhile?. European Journal of Cancer. 51(12). 1529–1537. 23 indexed citations

2.

Hertzberg, Mark, et al.. (2006). Outpatient fractionated ifosfamide, carboplatin and etoposide as salvage therapy in relapsed and refractory non-Hodgkin's and Hodgkin's lymphoma. Annals of Oncology. 17. iv25–iv30. 27 indexed citations

3.

Hertzberg, Mark, et al.. (2003). Outpatient-based ifosfamide, carboplatin and etoposide (ICE) chemotherapy in transplant-eligible patients with non-Hodgkin’s lymphoma and Hodgkin’s disease. Annals of Oncology. 14. i11–i16. 32 indexed citations

4.

Shannon, Catherine, et al.. (2001). Carboplatin and gemcitabine in metastatic transitional cell carcinoma of the urothelium: Effective treatment of patients with poor prognostic features. Annals of Oncology. 12(7). 947–952. 44 indexed citations

5.

Stuart‐Harris, R., Derek Raghavan, R. H. Fox, et al.. (1987). CHEMOTHERAPY FOR SMALL CELL LUNG CANCER: INPUCTION AND REINDUCTION WITH VOCA. Australian and New Zealand Journal of Medicine. 17(3). 279–282. 4 indexed citations

6.

Crombie, Catherine, et al.. (1987). Phase II Study of Megestrol Acetate for Metastatic Carcinoma of the Prostate. British Journal of Urology. 59(5). 443–446. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact